PubMed=18059259; DOI=10.1038/nbt1374
Nakagawa M., Koyanagi M., Tanabe K., Takahashi K., Ichisaka T., Aoi T., Okita K., Mochiduki Y., Takizawa N., Yamanaka S.
Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts.
Nat. Biotechnol. 26:101-106(2008)

PubMed=21098095; DOI=10.1084/jem.20100844; PMCID=PMC3005234
Takayama N., Nishimura S., Nakamura S., Shimizu T., Ohnishi R., Endo H., Yamaguchi T., Otsu M., Nishimura K., Nakanishi M., Sawaguchi A., Nagai R., Takahashi K., Yamanaka S., Nakauchi H., Eto K.
Transient activation of c-MYC expression is critical for efficient platelet generation from human induced pluripotent stem cells.
J. Exp. Med. 207:2817-2830(2010)

PubMed=22056147; DOI=10.1016/j.scr.2011.10.002
Kunisada Y., Tsubooka-Yamazoe N., Shoji M., Hosoya M.
Small molecules induce efficient differentiation into insulin-producing cells from human induced pluripotent stem cells.
Stem Cell Res. 8:274-284(2012)

PubMed=22802639; DOI=10.1073/pnas.1209979109; PMCID=PMC3411998
Kajiwara M., Aoi T., Okita K., Takahashi R., Inoue H., Takayama N., Endo H., Eto K., Toguchida J., Uemoto S., Yamanaka S.
Donor-dependent variations in hepatic differentiation from human-induced pluripotent stem cells.
Proc. Natl. Acad. Sci. U.S.A. 109:12538-12543(2012)

PubMed=24259714; DOI=10.1073/pnas.1319061110; PMCID=PMC3870695
Koyanagi-Aoi M., Ohnuki M., Takahashi K., Okita K., Noma H., Sawamura Y., Teramoto I., Narita M., Sato Y., Ichisaka T., Amano N., Watanabe A., Morizane A., Yamada Y., Sato T., Takahashi J., Yamanaka S.
Differentiation-defective phenotypes revealed by large-scale analyses of human pluripotent stem cells.
Proc. Natl. Acad. Sci. U.S.A. 110:20569-20574(2013)

PubMed=27476965; DOI=10.1016/j.stem.2016.06.019
Nishizawa M., Chonabayashi K., Nomura M., Tanaka A., Nakamura M., Inagaki A., Nishikawa M., Takei I., Oishi A., Tanabe K., Ohnuki M., Yokota H., Koyanagi-Aoi M., Okita K., Watanabe A., Takaori-Kondo A., Yamanaka S., Yoshida Y.
Epigenetic variation between human induced pluripotent stem cell lines is an indicator of differentiation capacity.
Cell Stem Cell 19:341-354(2016)

PubMed=27806289; DOI=10.1016/j.celrep.2016.10.026
Ishida Y., Kawakami H., Kitajima H., Nishiyama A., Sasai Y., Inoue H., Muguruma K.
Vulnerability of Purkinje cells generated from spinocerebellar ataxia type 6 patient-derived iPSCs.
Cell Rep. 17:1482-1490(2016)

PubMed=28453617; DOI=10.1093/biolre/iox038
Yokobayashi S., Okita K., Nakagawa M., Nakamura T., Yabuta Y., Yamamoto T., Saitou M.
Clonal variation of human induced pluripotent stem cells for induction into the germ cell fate.
Biol. Reprod. 96:1154-1166(2017)

DOI=10.1016/j.gendis.2024.101506
Okumura H., Hayashi M., Yamashita H., Hattori F.
Establishment and characterization of an induced pluripotent stem cell line from a Japanese cystic fibrosis patient with homozygous 1540del10 CFTR mutation.
Genes Dis. 0:0-0(2025)